Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Drugs Being Dropped by U.S. Insurers in 2017 Are Available Outside of U.S. for One-Quarter the Price, According to PharmacyChecker
  • USA - English


News provided by

PharmacyChecker.com

Dec 23, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX


White Plains, NY (PRWEB) December 23, 2016 -- Many Americans will be shocked in January when they are told to pay more for a single pill than they used to pay for an entire month’s supply of their medication due to formulary changes being made by major pharmacy benefits managers. Often, however, these drugs are already available from licensed pharmacies outside the U.S. at prices 74% lower on average than in the U.S., according to an analysis by PharmacyChecker.com.

If you are unable to switch to another drug and can’t afford the new price, be aware that the same drugs are available online at much lower cost from licensed pharmacies in other countries

Post this

“If you are unable to switch to another drug and can’t afford the new price, be aware that the same drugs are available online at much lower cost from licensed pharmacies in other countries,” said Tod Cooperman, M.D., CEO of PharmacyChecker.com.

The antidepressant Effexor XR (75 mg), for example, which is being dropped by CVS Caremark, costs about $11 per pill in the U.S. Licensed pharmacies sell the same pill for $3.25 in Canada, $1.80 in the UK, and just 65 cents in Turkey.

10 Drugs Being Dropped by Insurers in 2017 -- U.S. vs. Canada Prices

Xenazine (Tetrabenazine) 25 mg cost 94.86 per pill in the U.S. vs. $6.86 in Canada

Nexium (Omeprazole Magnesium) 40mg cost $6.90 per pill in the U.S. vs. $2.87 in Canada

Crestor (Rosuvastatin - 10mg cost $6.82 per pill in the U.S. vs $2.58 in Canada

Effexor XR (Venalfaxine) - 75mg cost $10.96 per pill in the U.S. vs. $3.25 in Canada

Abilify (Aripiprazole) - 5mg cost $29.88 per pill in the U.S. vs. $7.54 in Canada

Pradaxa (Dabigatan) - 150 mg cost $5.94 per pill in the U.S. vs. $3.13 in Canada

Tasigna (Nilotinib) Dose Pack - 150mg cost $93.84 per pill in the U.S. vs. $35.57 in Canada

Ventolin HFA (Albuterol) inhaler - 90 mcg cost $73.19 per pill in the U.S. vs. $35.10 in Canada

Zyclara Pump (Imiquimod) - 3.75%* cost $1,040.83 per pill in the U.S. vs. $414.75 in Canada

Xtandi (Enzalutamide) - 40mg cost $77.84 per pill in the U.S. vs. $40.50 in Canada

For all prices in analysis see: https://www.pharmacychecker.com/news/medications-dropped-from-pbms-2017-cost-less-outside-u.s.asp.

Sources: List based on formulary exclusions announced by CVS Caremark, except for Zyclara, which is being excluded by Express Scripts; U.S. prices shown are lowest prices from licensed pharmacies in Brooklyn, NY. Prices for other countries are from PharmacyChecker.com Verified Pharmacies, which require a valid prescription.

The largest potential savings -- 97% -- is for Xenazine (tetrabenazine), a drug that treats involuntary movements caused by Huntington’s Disease. In the U.S., the price is about $95 per pill, compared to $1.87 in New Zealand.

According to a recent poll by the Kaiser Family Foundation, about 19 million Americans report importing a medication for personal use, but the practice, according to the FDA, remains illegal under most circumstances. Lawfully manufactured medications imported for personal use from Canada and other countries are considered unapproved by the FDA. FDA spokesperson Christopher Kelly states, "FDA is not aware of any actions taken against an individual resulting from their purchase of small quantities of unapproved drugs for personal use." [1]

PharmacyChecker.com, founded in 2002, provides consumers with information to assess and compare online pharmacies and save money on medication.

For more information, contact Gabriel Levitt, President, PharmacyChecker.com at 718-387-4526 or gabriel.levitt(at)pharmacychecker(dot)com.

[1] “Should You Use an Overseas Pharmacy,” MoneyTalksNews.com, 2/1/2013. See http://www.moneytalksnews.com/is-it-safe-to-use-an-overseas-pharmacy/.

Gabriel Levitt, PharmacyChecker.com, +1 7183874526, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.